Posted On: 02/01/2013 10:18:42 AM
Post# of 68
Up 10% today!
EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer
(0)
(0)Scroll down for more posts ▼
